Family Healthcare, P.c. - Medicare Primary Care in Germantown, MD

Family Healthcare, P.c. is a medicare enrolled primary clinic (Family Medicine) in Germantown, Maryland. The current practice location for Family Healthcare, P.c. is 20528 Boland Farm Rd, Suite 104, Germantown, Maryland. For appointments, you can reach them via phone at (301) 972-0400. The mailing address for Family Healthcare, P.c. is 20528 Boland Farm Rd, Suite 104, Germantown, Maryland and phone number is (301) 972-0400.

Family Healthcare, P.c. is licensed to practice in Maryland (license number D0006258). The clinic also participates in the medicare program and its NPI number is 1053539122. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (301) 972-0400.

Contact Information

Family Healthcare, P.c.
20528 Boland Farm Rd
Suite 104
Germantown
MD 20876-4021
(301) 972-0400
(301) 916-1453

Primary Care Clinic Profile

Full NameFamily Healthcare, P.c.
SpecialityFamily Medicine
Location20528 Boland Farm Rd, Germantown, Maryland
Authorized Official Name and PositionMonica H Howard (MANAGING PARTNER)
Authorized Official Contact3019720400
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Family Healthcare, P.c.
20528 Boland Farm Rd
Suite 104
Germantown
MD 20876-4021

Ph: (301) 972-0400
Family Healthcare, P.c.
20528 Boland Farm Rd
Suite 104
Germantown
MD 20876-4021

Ph: (301) 972-0400

NPI Details:

NPI Number1053539122
Provider Enumeration Date04/23/2007
Last Update Date05/10/2016

Medicare PECOS Information:

Medicare PECOS PAC ID2567451156
Medicare Enrollment IDO20040510000225

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Family Healthcare, P.c. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053539122NPI-NPPES
1659423267OtherMHPERSONAL NPI NUMBER

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine D0006258 (Maryland)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Family Healthcare, P.c. acts as a billing entity for following providers:
Provider NameMegan B Wollman-rosenwald
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1730231564
PECOS PAC ID: 0547226912
Enrollment ID: I20041207000945

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameMichael Gee
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1982869814
PECOS PAC ID: 0143366609
Enrollment ID: I20091014000261

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameJamshid I Sheikh
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1720134406
PECOS PAC ID: 4789718552
Enrollment ID: I20100816000406

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameMonica J Howard
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1720130255
PECOS PAC ID: 1355536756
Enrollment ID: I20101209000730

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameRita R Sharma
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1982880365
PECOS PAC ID: 1759552540
Enrollment ID: I20110928000255

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameLeon W Kao
Provider TypePractitioner - Allergy/immunology
Provider IdentifiersNPI Number: 1265639728
PECOS PAC ID: 6709939358
Enrollment ID: I20130524000283

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameJennifer D Treat
Provider TypePractitioner - Physician Assistant
Provider IdentifiersNPI Number: 1033541982
PECOS PAC ID: 3779808878
Enrollment ID: I20150212001346

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameAvi Schachter
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1063471845
PECOS PAC ID: 8729024948
Enrollment ID: I20151203001561

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

Provider NameKharia J Holmes
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1265668347
PECOS PAC ID: 7214176551
Enrollment ID: I20160831000134

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more Medical News

› Verified 7 days ago

News Archive

May Institute, Borders partner to raise funds for critical services during Benefit Days

May Institute, an award-winning national nonprofit serving children and adults with autism and other special needs, and Borders, a leading specialty retailer of books as well as other educational and entertainment items, are partnering this holiday season to raise funds for critical services during May Institute's Benefit Days at Borders, December 3-5, 2010. Visit May Institute's website to download a voucher with the promotional code for this special fundraising event.

Substances in coffee could help quash risk of developing diabetes

In recent years, researchers have identified substances in coffee that could help quash the risk of developing Type 2 diabetes. But few of these have been tested in animals. Now in study appearing in ACS' Journal of Natural Products, scientists report that one of these previously untested compounds appears to improve cell function and insulin sensitivity in laboratory mice.

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure.

Breast cancer breakthrough

A team of researchers, led by Dr Clare Fedele and Professor Christina Mitchell at Monash University, Australia, has made a significant discovery in breast cancer research that identifies a particular protein's role in tumor growth. They have also devised a new antibody that can identify the protein and measure its presence in breast cancer tissue.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

Read more News

› Verified 7 days ago


Family Medicine in Germantown, MD

Germantown Health Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 12900 Middlebrook Rd, Germantown, MD 20874
Phone: 240-777-3272    
Germantown Reproductive Health Services, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 13233 Executive Park Ter, Germantown, MD 20874
Phone: 301-353-9200    Fax: 301-601-4318
Vatti T Anthony Md Pc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4 Executive Park Ct, Germantown, MD 20874
Phone: 301-916-1119    Fax: 301-540-2682
Mobile Medical Care, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 19735 Germantown Rd, Suite 300, Germantown, MD 20874
Phone: 301-634-9600    
Vinu Ganti M.d., P.c.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 19529 Doctors Dr, Germantown, MD 20874
Phone: 301-540-8146    Fax: 301-540-8162
Mangat And Kaur Inc.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 20528 Boland Farm Rd Ste 109, Germantown, MD 20876
Phone: 301-515-3333    Fax: 301-515-3322

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.